Person

Bruce I. Sachs

Director, Vertex Pharmaceuticals

Current S&P 500 boards
1
Current roles
1
Open-market buys
$8.2M
Open-market sales
$38.3M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 6, 2025VRTXBuy1,634$389.36$636K
Aug 6, 2025VRTXBuy3,366$389.84$1.3M
Aug 1, 2024VRTXSale5,295$508.00$2.7M
May 22, 2024VRTXSale7,073$448.00$3.2M
Nov 6, 2023VRTXSale11,250$385.00$4.3M
Jul 17, 2023VRTXSale5,711$356.75$2.0M
Jul 17, 2023VRTXSale3,842$357.29$1.4M
Jul 17, 2023VRTXSale1,697$355.54$603K
Apr 12, 2023VRTXSale8,026$327.48$2.6M
Apr 12, 2023VRTXSale10,357$326.46$3.4M
Apr 12, 2023VRTXSale2,917$325.65$950K
Jan 31, 2023VRTXSale1,200$325.01$390K
Aug 2, 2021VRTXBuy15,000$197.91$3.0M
Nov 10, 2020VRTXBuy4,270$217.49$929K
Nov 10, 2020VRTXBuy3,905$218.79$854K
Nov 10, 2020VRTXBuy6,825$216.47$1.5M
May 7, 2020VRTXSale2,960$272.46$806K
May 7, 2020VRTXSale6,232$271.63$1.7M
May 7, 2020VRTXSale5,889$270.49$1.6M
May 7, 2020VRTXSale15,751$269.53$4.2M
May 7, 2020VRTXSale11,568$268.65$3.1M
May 7, 2020VRTXSale2,600$267.50$696K
Jan 31, 2020VRTXSale1,200$232.04$278K
Jan 31, 2020VRTXSale1,800$233.13$420K
Jan 31, 2020VRTXSale900$234.15$211K
Jan 31, 2020VRTXSale100$235.40$24K
Jan 31, 2020VRTXSale1,700$224.02$381K
Jan 31, 2020VRTXSale1,858$224.98$418K
Jan 31, 2020VRTXSale4,198$226.32$950K
Jan 31, 2020VRTXSale5,644$227.01$1.3M
Jan 31, 2020VRTXSale300$227.66$68K
Jan 31, 2020VRTXSale600$228.33$137K
Jan 31, 2020VRTXSale500$229.90$115K
Jan 31, 2020VRTXSale1,200$230.87$277K

SEC reporting-owner ID (CIK) 1197036 · all filings on EDGAR